| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | 914,2 k € | +15.7% | 789,8 k € | +13.3% | 697,2 k € | +30.3% | 535,1 k € | +93.4% | 276,7 k € | -18.0% | 337,4 k € | +2.1% | 330,5 k € | +32.0% | 250,4 k € | +96.4% | 127,5 k € | -48.2% | 245,9 k € | ||||||
| Gross margin | 41,4 k € | +52.8% | 27,1 k € | -21.1% | 34,3 k € | -88.3% | 293,7 k € | -15.9% | 349,2 k € | -13.7% | 404,8 k € | +20.0% | 337,3 k € | -2.8% | 346,9 k € | +87.1% | 185,4 k € | — | — | — | — | — | — | |||||||
| EBITDA | 37,1 k € | +64.3% | 22,6 k € | +154.5% | -41,5 k € | -125.0% | 166,2 k € | -26.7% | 226,7 k € | -20.1% | 283,6 k € | +23.7% | 229,3 k € | -5.1% | 241,7 k € | +192.1% | 82,7 k € | +232.9% | -62,2 k € | -43.7% | -43,3 k € | +53.0% | -92,2 k € | +9.6% | -102,0 k € | +42.6% | -177,5 k € | -134.9% | -75,5 k € | |
| Operating profit | 138,3 k € | +1061.1% | 11,9 k € | +105.3% | -223,9 k € | -292.9% | 116,0 k € | -43.8% | 206,3 k € | -21.7% | 263,7 k € | +20.1% | 219,6 k € | -9.1% | 241,7 k € | +192.5% | 82,6 k € | +214.0% | -72,5 k € | -22.5% | -59,2 k € | +47.3% | -112,3 k € | +13.3% | -129,5 k € | +37.0% | -205,7 k € | -122.8% | -92,3 k € | |
| Profit/loss | 137,4 k € | +1087.0% | 11,6 k € | +105.1% | -225,8 k € | -296.8% | 114,7 k € | -50.2% | 230,4 k € | -10.2% | 256,5 k € | +23.7% | 207,4 k € | -9.2% | 228,4 k € | +331.7% | 52,9 k € | +145.9% | -115,2 k € | -26.9% | -90,8 k € | -8.2% | -83,9 k € | +37.1% | -133,5 k € | +35.2% | -205,9 k € | -122.3% | -92,6 k € | |
| Equity | 370,7 k € | -23.3% | 483,3 k € | +2.5% | 471,7 k € | -32.4% | 697,5 k € | +19.7% | 582,8 k € | +65.4% | 352,3 k € | +267.8% | 95,8 k € | +185.8% | -111,6 k € | +67.2% | -340,0 k € | +13.5% | -392,9 k € | -41.5% | -277,7 k € | -48.5% | -187,0 k € | -81.4% | -103,1 k € | -718.5% | 16,7 k € | -84.3% | 106,3 k € | |
| Total assets | 712,4 k € | +20.7% | 590,4 k € | +6.3% | 555,2 k € | -38.4% | 901,9 k € | +16.7% | 772,7 k € | +26.1% | 612,7 k € | +20.4% | 509,0 k € | -16.9% | 612,7 k € | +71.9% | 356,4 k € | +41.8% | 251,4 k € | +1.6% | 247,5 k € | +22.1% | 202,7 k € | -10.1% | 225,6 k € | -6.2% | 240,6 k € | -9.3% | 265,2 k € | |
| Cash | 240,3 k € | -8.0% | 261,2 k € | +238.7% | 77,1 k € | +41.1% | 54,6 k € | +198.2% | 18,3 k € | -21.6% | 23,4 k € | +71.6% | 13,6 k € | -68.8% | 43,7 k € | +40.3% | 31,2 k € | +86.9% | 16,7 k € | +23.1% | 13,5 k € | -10.7% | 15,2 k € | -77.4% | 67,1 k € | +115.4% | 31,1 k € | -52.2% | 65,1 k € | |
| Debts | 341,7 k € | +219.0% | 107,1 k € | +28.3% | 83,5 k € | -59.2% | 204,4 k € | +8.5% | 188,4 k € | -27.6% | 260,4 k € | -35.3% | 402,8 k € | -44.1% | 720,1 k € | +4.9% | 686,2 k € | +9.8% | 625,1 k € | +19.0% | 525,1 k € | +38.3% | 379,6 k € | +15.8% | 327,9 k € | +46.4% | 223,9 k € | +40.9% | 158,9 k € | |
| Staff | — | — | 0,6 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | |||||||||||||||
Public limited company · Tessenderlo-Ham · incorporated on 17/09/2010
Public limited company profitable and well capitalised. Cash position declining (-8.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Reskin Medical is a Public limited company incorporated in 2010. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Tessenderlo-Ham.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette